<DOC>
	<DOCNO>NCT01740362</DOCNO>
	<brief_summary>A study evaluate pharmacokinetics CP-690,550 subject mild , moderate severe renal impairment , require hemodialysis , compare healthy control .</brief_summary>
	<brief_title>Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Subjects normal renal function : Subjects must healthy estimate creatinine clearance &gt; 80 mL/min Subjects renal impairment : Subjects good general health commensurate population chronic kidney disease Kidney transplant patient Subjects condition possibly affect drug absorption Subjects malignancies exception adequately treat basal cell carcinoma skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>CP-690</keyword>
	<keyword>550</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>renal impairment</keyword>
</DOC>